Harrow Health
Price & Volume
Stats
See more52W Range | $28.54-$54.85 |
Market Cap | $1.5B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $268.6M |
Revenue Growth (YoY) | -7.6% |
Gross Profit (12 Mos) | $199.1M |
Diluted EPS | -$0.38 |
News
See moreYahoo Finance • 10 days ago
Harrow Announces Commercial Launch of BYOOVIZ® in the United States
Yahoo Finance • 10 days ago
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
Yahoo Finance • 18 days ago
GROW Small Cap Equity Fund Covered Its Position in Harrow (HROW) in Q1
Yahoo Finance • 28 days ago
Is Harrow, Inc. (HROW) A Good Stock To Buy Now?
About
CEO | Mr. Mark L. Baum J.D. |
CFO | Mr. Andrew R. Boll C.F.A., C.M.A. |
Address | 1A Burton Hills Boulevard, Nashville, TN, United States, 37215 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 373 |